Entrada Therapeutics Inc.

TRDA | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.82

+$0.18 (+2.71%)

Sep 22, 2026, 12:45 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	90.39M	101.21M	67.6M	45.16M	291.06M	39.05M
Short-Term Investments	205.3M	318.79M	284.37M	143.56M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	3.36M	4.23M	6.74M	9.16M	872K	541K
Receivables	2.58M	3.68M	5.88M	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	7.98M	16.36M	11.92M	21.16M	n/a	n/a
Total Current Assets	306.25M	440.04M	369.77M	209.88M	298.7M	39.95M
Property-Plant & Equipment	67.76M	82.05M	92.68M	33.02M	6.26M	3.04M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	71.13M	86.28M	99.42M	42.18M	7.13M	3.58M
Total Assets	377.38M	526.32M	469.19M	252.06M	305.83M	43.53M
Account Payables	2.29M	4.26M	3.28M	5.99M	706K	1.6M
Deferred Revenue	342K	13.65M	132.26M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	9.22M	8.43M	7.66M	5.49M	4.56M	1.6M
Total Current Liabilities	24.45M	39.48M	158.8M	21.97M	6.72M	3.36M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	396K	81.66M
Total Long-Term Liabilities	46.79M	58.16M	68.04M	17.53M	396K	81.66M
Total Liabilities	71.25M	97.64M	226.83M	39.5M	7.12M	85.02M
Total Debt	50.93M	59.21M	68.23M	25.94M	n/a	n/a
Book Value	306.13M	428.68M	242.36M	212.55M	298.72M	-41.49M
Book Value Per Share	7.40	10.99	7.33	6.79	9.57	-1.33
Common Stock	4K	4K	3K	3K	3K	n/a
Retained Earnings	-273.09M	-129.34M	-194.97M	-188.29M	-93.67M	-42.51M
Comprehensive Income	652K	-43K	195K	-2.06M	0	n/a
Shareholders Equity	306.13M	428.68M	242.36M	212.55M	298.72M	-41.49M
Total Investments	205.3M	318.79M	284.37M	143.56M	n/a	n/a